[Other] New Antibiotics for Resistant Infections: What Happens After Approval? |
Reward20points
Best Answer
2024-4-25
|
| |
30
Addition of daratumumab to lenalidomide, bortezomib, and dexamethasone for transplantation-eligible patients with newly diagnosed multiple myeloma (GRIFFIN): final analysis of an open-label, randomised, phase 2 trial
20
Springer Article
10
A differential-based method for correcting ultra-short baseline positioning results
20
Job Insecurity and Well-Being: Integrating Life History and Transactional Stress Theories
20
New subtype of acute odontoid fractures (type IIA)
